CGT

774개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved774 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

CGTLimited DatastaleMedical College of WisconsinPhase 1

2.5 x10^5 CAR-20/19-T cells/kg (CAR-20/19-T cells, CAR-20/19-T cells (2.5 x10^5 CAR-20/19-T cells/kg))

Lymphoma, Non-Hodgkin; Lymphoma, B-Cell · Lymphoma, Non-Hodgkin

#LymphomaNon-Hodgkin#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 3Status Active
CGTLimited DatastaleMedical College of WisconsinPhase 1

2.5 x10^6 CAR-20/19-T cells/kg (CAR-20/19-T cells, CAR-20/19-T cells (2.5 x10^6 CAR-20/19-T cells/kg))

Lymphoma, Non-Hodgkin; Lymphoma, B-Cell · Lymphoma, Non-Hodgkin

#LymphomaNon-Hodgkin#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 3Status Active
CGTLimited DatastaleMedical College of WisconsinPhase 1

7.5 x10^5 CAR-20/19-T cells/kg (CAR-20/19-T cells, CAR-20/19-T cells (7.5 x10^5 CAR-20/19-T cells/kg))

Lymphoma, Non-Hodgkin; Lymphoma, B-Cell · Lymphoma, Non-Hodgkin

#LymphomaNon-Hodgkin#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 3Status Active
CGTLimited DatastaleCARsgen Therapeutics Co., Ltd.Phase 2

CAR-BCMA T Cells (CAR-BCMA T Cells)

Refractory or Relapsed Multiple Myeloma · BCMA

#BCMA#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 3Status Active
CGTLimited DatastaleUniversity of PennsylvaniaPhase 1

CART22-65s cells (CART22-65s cells)

Chemotherapy Resistant Acute Lymphoblastic Leukemia; Refractory Acute Lymphoblastic Leukemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 3Status Recruiting
CGTLimited DatastaleUniversity of PennsylvaniaPhase 1

RNA CART19 cells (CD19 RNA redirected autologous T-cells, CD19 RNA redirected autologous T-cells (RNA CART19 cells))

Hodgkin Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 3Status Discontinued
CGTLimited DatastaleKecellitics Biotech Company LtdPhase 2

CD19 and CD22 targeted CAR-T cells (CD19 and CD22 targeted CAR-T cells)

Lymphoma, B-Cell · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 3Status Active
CGTLimited DatastaleInnovative Cellular Therapeutic…Preclinical

CD19CART (CD19CART)

Leukemia, B-Cell; Lymphoma, B-Cell · CD19

#CD19#CGT#Preclinical#cell-gene-therapy#CAR-T+5
Trials 3Status Active
CGTLimited DatastaleBeijing BiotechPhase 1

CD20/BCMA-directed CAR-T cells (CD20/BCMA-directed CAR-T cells)

Systemic Lupus Erythematosus (SLE); Immune-mediated Necrotizing Myopathy (IMNM) · CD20

#CD20#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 3Status Recruiting
CGTLimited DatastaleBaylor College of MedicinePhase 1

CD30.CAR-EBVST cells (CD30.CAR-EBVST cells)

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type; Classical Hodgkin Lymphoma · CD30

#CD30#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 3Status Discontinued
CGTLimited DatastalePersonGen BioTherapeutics (Suzh…Phase 2

Humanized CD7 CAR-T cells (Humanized CD7 CAR-T cells)

Refractory and Relapsed T Cell Lymphoma · T Lymphoblastic Leukemia/Lymphoma

#TLymphoblasticLeukemiaLymphoma#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 3Status Active
CGTLimited DatastaleBeijing Immunochina Medical Sci…Phase 1

IM96 CAR-T cells (IM96 CAR-T cells)

Adenocarcinoma of Gastric; Adenocarcinoma of Esophagogastric Junction · Advanced Solid Tumors

#AdvancedSolidTumors#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 3Status Recruiting
CGTLimited DatastaleNovatim Immune Therapeutics (Zh…Phase 2

KQ-2003 CAR T-cells (KQ-2003 CAR T-cells)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 3Status Active
CGTLimited DatastaleNanjing Legend Biotech Co.Phase 1

LCAR-AIO T cells (LCAR-AIO T cells)

Multiple Sclerosis (MS); Neuromyelitis Optica Spectrum Disease (NMOSD) · Systemic Lupus Erythematosus (SLE)

#SystemicLupusErythematosusSLE#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 3Status Discontinued
CGTLimited DatastalePeter MacCallum Cancer Centre, …Phase 1

LeY CAR T cells (LeY CAR T cells)

Advanced Cancer · Advanced Cancer

#AdvancedCancer#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 3Status Active
CGTLimited DatastaleMiltenyi Biomedicine GmbHPhase 1

MB-CART19.1 Cellular Therapy (MB-CART19.1 Cellular Therapy)

Primary Central Nervous System (CNS) Lymphoma; Secondary Central Nervous System Lymphoma · Primary Central Nervous System (CNS) Lym

#PrimaryCentralNervousSystemCNSLy#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 3Status Recruiting
CGTLimited DatastaleWuhan Sian Medical Technology C…Phase 1

Second generation humanized CAR-T cells (Second generation humanized CAR-T cells)

Acute Lymphoblastic Leukemia; B Cell Lymphoma · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 3Status Active
CGTLimited DatastaleCellectis S.A.Phase 1

UCART123 (UCART123)

Acute Myeloid Leukaemia · Acute Myeloid Leukaemia

#AcuteMyeloidLeukaemia#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 3Status Discontinued
CGTLimited DatastaleUniversity of Colorado, DenverPhase 1

UCD19 CAR T Cells (UCD19 CAR T Cells)

Non Hodgkin Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 3Status Active
CGTLimited DatastaleHrain Biotechnology Co., Ltd.Phase 1

anti-meso-CAR vector transduced T cells (anti-meso-CAR vector transduced T cells)

Malignant Mesothelioma; Pancreatic Cancer · Malignant Mesothelioma

#MalignantMesothelioma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 3Status Active

10 / 39 pages

← PreviousNext →